Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Henderson, Nevada
- Most recent report
- 10-Q, filed Aug 10, 2026
- Incorporated
- Colorado
- Filings on record
- 71 filings
- On EDGAR
- CIK 1145604
- Fiscal year ends
- December
- Filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
Financials 8 of 26
News 8 of 13
- 8-K Current report on a material event Oct 16, 2024
- 8-K Current report on a material event Oct 1, 2024
- 8-K Acquisition or disposal closed Aug 27, 2024
- 8-K Acquisition or disposal closed May 10, 2024
- 8-K Acquisition or disposal closed Apr 15, 2024
- 8-K Acquisition or disposal closed Mar 5, 2024
- 8-K Current report on a material event Feb 16, 2024
- 8-K Significant contract Sep 18, 2023
Prospectuses and Registrations 2
Ownership 4
Other 8 of 26
- UPLOAD Comment letter from SEC staff Oct 8, 2024
- RW Sep 19, 2024
- RW Sep 16, 2024
- RW Sep 12, 2024
- NT 10-Q Notice that a quarterly report will be late Aug 14, 2024
- CORRESP Reply to SEC staff Jun 24, 2024
- UPLOAD Comment letter from SEC staff Jun 14, 2024
- NT 10-Q Notice that a quarterly report will be late May 16, 2024
Everything here comes from Nika Pharmaceuticals, Inc's own filings on SEC EDGAR. The filing list is rechecked every hour.